scispace - formally typeset
Open AccessJournal ArticleDOI

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

Reads0
Chats0
TLDR
It is demonstrated that miRNAs are present in the serum and plasma of humans and other animals such as mice, rats, bovine fetuses, calves, and horses, and can serve as potential biomarkers for the detection of various cancers and other diseases.
Abstract
Dysregulated expression of microRNAs (miRNAs) in various tissues has been associated with a variety of diseases, including cancers. Here we demonstrate that miRNAs are present in the serum and plasma of humans and other animals such as mice, rats, bovine fetuses, calves, and horses. The levels of miRNAs in serum are stable, reproducible, and consistent among individuals of the same species. Employing Solexa, we sequenced all serum miRNAs of healthy Chinese subjects and found over 100 and 91 serum miRNAs in male and female subjects, respectively. We also identified specific expression patterns of serum miRNAs for lung cancer, colorectal cancer, and diabetes, providing evidence that serum miRNAs contain fingerprints for various diseases. Two non-small cell lung cancer-specific serum miRNAs obtained by Solexa were further validated in an independent trial of 75 healthy donors and 152 cancer patients, using quantitative reverse transcription polymerase chain reaction assays. Through these analyses, we conclude that serum miRNAs can serve as potential biomarkers for the detection of various cancers and other diseases.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

miR-125a-5p is a prognostic biomarker that targets HDAC4 to suppress breast tumorigenesis

TL;DR: It is demonstrated that serum miR-125a-5p level in breast cancer may be a useful prognostic biomarker and offer a novel therapeutic avenue by targeting HDAC4 in Breast cancer.
Journal ArticleDOI

Higher expression of circulating miR-182 as a novel biomarker for breast cancer.

TL;DR: Results consistent with miR-182 as a novel and valuable biomarker for the diagnosis of BC are highlighted.
Journal ArticleDOI

Intracellular modulation, extracellular disposal and serum increase of MiR-150 mark lymphocyte activation.

TL;DR: It is found that, upon activation in vitro, human and mouse lymphocytes down-modulate intracellular miR-150 and accumulate it in exosomes, which suggests that the selective extracellular disposal of microRNAs can be a rapid way to regulate gene expression during lymphocyte activation.
Journal ArticleDOI

A combination of circulating miRNAs for the early detection of ovarian cancer

TL;DR: This method was able to successfully distinguish ovarian cancer patients from healthy controls and early-stage ovarian cancer from patients with benign tumors, and enables subtype classification in 4 types of epithelial ovarian cancer.
References
More filters
Journal Article

MicroRNA signatures in human cancers

TL;DR: The causes of the widespread differential expression of miRNA genes in malignant compared with normal cells can be explained by the location of these genes in cancer-associated genomic regions, by epigenetic mechanisms and by alterations in the miRNA processing machinery as discussed by the authors.
Journal Article

Oncomirs : microRNAs with a role in cancer

TL;DR: I MicroRNAs (miRNAs) are an abundant class of small non-protein-coding RNAs that function as negative gene regulators as discussed by the authors, and have been shown to repress the expression of important cancer-related genes and might prove useful in the diagnosis and treatment of cancer.
Journal ArticleDOI

Real-time quantification of microRNAs by stem–loop RT–PCR

TL;DR: A novel microRNA quantification method has been developed using stem–loop RT followed by TaqMan PCR analysis, which enables fast, accurate and sensitive miRNA expression profiling and can identify and monitor potential biomarkers specific to tissues or diseases.
Related Papers (5)